STABLE INTRAVENOUS FORMULATION

STABLE INTRAVENOUS FORMULATION

A stable lyophilized formulation for intravenous administration of the compound 4-{[(2R, 3S, 55)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)- pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic Acid 1-[2-(2-methoxy-ethoxy)-ethoxycarbonyloxy]-ethyl ester is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: INBAR, PETRA, GALASSO, ANTHONY, N, SAMPAT, HARENDRA, R, ZHAN, SHANGDONG, QURESHI, FAROOQ
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator INBAR, PETRA
GALASSO, ANTHONY, N
SAMPAT, HARENDRA, R
ZHAN, SHANGDONG
QURESHI, FAROOQ
description A stable lyophilized formulation for intravenous administration of the compound 4-{[(2R, 3S, 55)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)- pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic Acid 1-[2-(2-methoxy-ethoxy)-ethoxycarbonyloxy]-ethyl ester is provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3013316A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3013316A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3013316A13</originalsourceid><addsrcrecordid>eNrjZJALDnF08nFV8PQLCXIMc_XzDw1WcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGBobGxoZmjobGRCgBAJNDITg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE INTRAVENOUS FORMULATION</title><source>esp@cenet</source><creator>INBAR, PETRA ; GALASSO, ANTHONY, N ; SAMPAT, HARENDRA, R ; ZHAN, SHANGDONG ; QURESHI, FAROOQ</creator><creatorcontrib>INBAR, PETRA ; GALASSO, ANTHONY, N ; SAMPAT, HARENDRA, R ; ZHAN, SHANGDONG ; QURESHI, FAROOQ</creatorcontrib><description>A stable lyophilized formulation for intravenous administration of the compound 4-{[(2R, 3S, 55)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)- pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic Acid 1-[2-(2-methoxy-ethoxy)-ethoxycarbonyloxy]-ethyl ester is provided.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160504&amp;DB=EPODOC&amp;CC=EP&amp;NR=3013316A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160504&amp;DB=EPODOC&amp;CC=EP&amp;NR=3013316A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>INBAR, PETRA</creatorcontrib><creatorcontrib>GALASSO, ANTHONY, N</creatorcontrib><creatorcontrib>SAMPAT, HARENDRA, R</creatorcontrib><creatorcontrib>ZHAN, SHANGDONG</creatorcontrib><creatorcontrib>QURESHI, FAROOQ</creatorcontrib><title>STABLE INTRAVENOUS FORMULATION</title><description>A stable lyophilized formulation for intravenous administration of the compound 4-{[(2R, 3S, 55)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)- pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic Acid 1-[2-(2-methoxy-ethoxy)-ethoxycarbonyloxy]-ethyl ester is provided.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJALDnF08nFV8PQLCXIMc_XzDw1WcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGBobGxoZmjobGRCgBAJNDITg</recordid><startdate>20160504</startdate><enddate>20160504</enddate><creator>INBAR, PETRA</creator><creator>GALASSO, ANTHONY, N</creator><creator>SAMPAT, HARENDRA, R</creator><creator>ZHAN, SHANGDONG</creator><creator>QURESHI, FAROOQ</creator><scope>EVB</scope></search><sort><creationdate>20160504</creationdate><title>STABLE INTRAVENOUS FORMULATION</title><author>INBAR, PETRA ; GALASSO, ANTHONY, N ; SAMPAT, HARENDRA, R ; ZHAN, SHANGDONG ; QURESHI, FAROOQ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3013316A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>INBAR, PETRA</creatorcontrib><creatorcontrib>GALASSO, ANTHONY, N</creatorcontrib><creatorcontrib>SAMPAT, HARENDRA, R</creatorcontrib><creatorcontrib>ZHAN, SHANGDONG</creatorcontrib><creatorcontrib>QURESHI, FAROOQ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>INBAR, PETRA</au><au>GALASSO, ANTHONY, N</au><au>SAMPAT, HARENDRA, R</au><au>ZHAN, SHANGDONG</au><au>QURESHI, FAROOQ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE INTRAVENOUS FORMULATION</title><date>2016-05-04</date><risdate>2016</risdate><abstract>A stable lyophilized formulation for intravenous administration of the compound 4-{[(2R, 3S, 55)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)- pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic Acid 1-[2-(2-methoxy-ethoxy)-ethoxycarbonyloxy]-ethyl ester is provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3013316A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title STABLE INTRAVENOUS FORMULATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A46%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=INBAR,%20PETRA&rft.date=2016-05-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3013316A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true